je.st
news
Home
› Compugen Discloses Focused Target Discovery Program For Antibody-Drug Conjugate Cancer Therapy
Compugen Discloses Focused Target Discovery Program For Antibody-Drug Conjugate Cancer Therapy
2013-04-02 09:55:00| drugdiscoveryonline News Articles
Compugen Ltd. disclosed recently the initiation of its second focused discovery program, aimed at identification of novel targets for antibody-drug conjugate (ADC) cancer therapy focusing on clinical situations with poor survival rates and/or recurrent cancers
Tags: program
target
cancer
focused
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||